Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy

Background: In heart transplant recipients, donor-derived cell-free DNA (ddcfDNA) is a potential biomarker for acute rejection (AR), in that increased values may indicate rejection. For the assessment of ddcfDNA as new biomarker for rejection, blood plasma sampling around the endomyocardial biopsy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, Jeroen G. H. P., Hesselink, Dennis A., Peeters, Annemiek M. A., de Jonge, Evert, von der Thüsen, Jan H., van Schaik, Ron H. N., Matic, Maja, Baan, Carla C., Manintveld, O. C., Boer, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977404/
https://www.ncbi.nlm.nih.gov/pubmed/35387397
http://dx.doi.org/10.3389/ti.2022.10122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977404/
https://www.ncbi.nlm.nih.gov/pubmed/35387397
http://dx.doi.org/10.3389/ti.2022.10122

Ejemplares similares